Management of Multiple Myeloma| PatientsEngage

Multiple Myeloma

Multiple myeloma is a blood cancer that forms in a plasma cell, a type of white blood cell. It is considered a rare cancer. Worldwide, an estimated 176,404 people were diagnosed with multiple myeloma in 2020. There were about 12,000 cases in India in 2020. Multiple myeloma is treatable and survival rates are better, especially if the disease is diagnosed early and treated.

Submitted by Dr S. Patel on 31 July 2023

Management of Multiple Myeloma

Supportive therapy is used for better management of complications, side-effects and other other issues related to cancer. For Multiple Myeloma, this can include:

Controlling nausea and vomiting with medications.
Bisphosphonates or bone-strengthening drugs to slow down bone damage.
Medications like monoclonal antibodies (denosumab) to prevent osteoporosis, and risk of fractures.
Hematopoietic growth factors or colony-stimulating factors to increase production of red and white blood cells.
Antibiotics to prevent and fight infections due to poor immunity. Strict hygiene protocols to prevent risk of any infections even simple cold and flu. Pneumoccocol, flu and covid vaccination should be taken as prescribed by your doctor.
Plasma exchange to reduce the hyperviscosity of the plasma with new plasma from a healthy donor. This is called termed Plasmapheresis.
Physical activity to counter bone loss but make sure you avoid injury.
For best kidney health, drink plenty of fluids especially if you have “bence-jones myeloma”. Avoid use of NSAIDS that can further damage your kidney.
Get a dental check-up to see if jaw and teeth have not been affected. Check for infection and side-effect of bisphosphonate use. If you need any dental procedures, make sure you consult your Oncologist on when you should get it done.

For lived experiences of people with multiple myeloma, click here

Changed

17/Apr/2025

Community

Cancer

Condition

Multiple Myeloma

Stories

Types and Stages of Multiple Myeloma

Types of Multiple Myeloma There are two main types of Multiple Myeloma, Smoldering and Active. Smoldering is also called asymptomatic or indolent myeloma because it shows no symptoms and signs and is slow growing. People need close monitoring every 3-6 months to check for progression. Active is also called symptomatic myeloma due to the presence of signs and symptoms. If it is present in the bone or soft tissue, it is termed plasmacytoma. Several subtypes are identified based on which…
Multiple Myeloma Test and Diagnosis

Tests for Diagnosing Multiple Myeloma Multiple myeloma is often diagnosed based on tests, the patient’s symptoms and the doctor’s physical exam of the patient. A diagnosis of multiple myeloma requires either: A plasma cell tumor (proven by biopsy) OR at least 10% plasma cells in the bone marrow AND At least one of the following CRAB criteria: High blood Calcium level (greater than 0.25 mmol/L) Poor Renal function with creatinine greater than 2mg/dL Anemia with red blood cell counts lower…
Prevention of Multiple Myeloma

Prevention of Multiple Myeloma Since the exact cause and risk factors of this cancer are unknown, there is no known way to prevent it. It is important to not ignore symptoms mentioned here and diagnose multiple myeloma early. References: https://www.cancer.net/cancer-types/multiple-myeloma https://www.cancer.org/cancer/types/multiple-myeloma.html https://www.cancercenter.com/cancer-types/multiple-myeloma/types lbagoush SA, Shumway C, Azevedo AM. Multiple Myeloma. [Updated…
Management of Multiple Myeloma

Management of Multiple Myeloma Supportive therapy is used for better management of complications, side-effects and other other issues related to cancer. For Multiple Myeloma, this can include: Controlling nausea and vomiting with medications. Bisphosphonates or bone-strengthening drugs to slow down bone damage. Medications like monoclonal antibodies (denosumab) to prevent osteoporosis, and risk of fractures. Hematopoietic growth factors or colony-stimulating factors to increase production of…
Multiple Myeloma Treatment

Treatment of Multiple Myeloma Treatment of Multiple Myeloma depends on the type of disease. For those with smoldering or symptomless disease, the watch and wait approach is used. This means monitoring is periodically done. For active myeloma, the treatment is phased out in 3 stages: Induction therapy is the 1st phase where the aim is to reduce the plasma cell and M-protein count. This can be done by chemo, targeted therapy and use of corticosteroids over a course of 3-6…
Multiple Myeloma Signs and Symptoms

Symptoms of Multiple Myeloma Multiple Myeloma is often symptomless in the early stages and difficult to diagnose. Symptoms may appear gradually as the underlying issues develop. Symptoms are usually multifactorial. Fatigue and reduced activity levels due to anemia (low blood count or poor kidney functioning. Shortness of breath due to anemia and exertion. Bone pain or fractures as the bone density has decreased. Pain is experience in the middle or lower back, ribs or hip area. Numbness…
Causes of Multiple Myeloma and Risk Factors

Causes of Multiple Myeloma The exact cause of multiple myeloma remains unknown. Genetic research shows that mutations in some oncogenes may be responsible for multiple myeloma. Certain factors that increase risk of Multiple Myeloma include: Age above 65 years Men more than women Family History Obesity Previous exposure to Radiation therapy Exposure to Environmental agents such as insecticides, organic solvents, and agent orange. Other Plasma cell Disorders. These include precancerous…
Overview of Multiple Myeloma

Overview Multiple Myeloma (MM) is also called Kahler’s disease. It is a cancer of the plasma cells. Plasma cells are normally found in the bone marrow and play an important part in our immune system. They are responsible for producing antibodies called immunoglobulins which attack and kill germs. When plasma cells become cancerous and divide rapidly, it is called Multiple Myeloma. Cancerours plsma cells make an abnormal protein called monoclonal immunoglobulin or M-protein/spike or…
मल्टीपल मायलोमा के निदान के बाद मैंने हर पल को सँजोना सीखा

कोलकाता के 56 वर्षीय रजत सुभ्रा बिस्वास को मल्टीपल मायलोमा का निदान मिला था और उनकी बीएमटी (बोन मैरो ट्रांसप्लांट) सर्जरी भी हुई है। इस लेख में वे अपनी मल्टीपल मायलोमा की यात्रा के बारे में बात करते हैं। मुझे सितंबर 2018 में मल्टीपल मायलोमा का निदान मिला था। मैं वर्तमान में रेमिशन में हूँ। शुरुआती लक्षण क्या थे? मैं धीरे-धीरे गुर्दे के कार्य में कमी का अनुभव कर रहा था, मूत्र में प्रोटीन के रिसाव में वृद्धि के साथ-साथ मेरा क्रिएटिनिन स्तर लगातार बढ़ रहा था। इसके अलावा, मुझे अत्यधिक थकान और त्वचा…
Cherishing Every Moment After A Multiple Myeloma Diagnosis

Rajat Subhra Biswas, 56 years old from Kolkata has lived with multiple myeloma and has even gone through a BMT surgery. He talks about his journey. I was diagnosed with multiple myeloma in September 2018. I am currently in remission. What were the early symptoms? I was experiencing gradual loss of renal function, my creatinine level was steadily increasing alongwith increased leakage of protein in urine. Further, I was experiencing extreme fatigue and regular pigmentation on the skin especially…